Articles written by BenzingaStaffB

UPDATE: J.P. Morgan Lowers Price Target on Taubman Centers to $67

UPDATE: J.P. Morgan Lowers Price Target on Taubman Centers to $67

UPDATE: Rodman & Renshaw Lower PT to $5.50 on BPZ Resources

UPDATE: Rodman & Renshaw Lower PT to $5.50 on BPZ Resources

UPDATE: Wunderlich Securities Raises PT to $16 on Netscout Systems

UPDATE: Wunderlich Securities Raises PT to $16 on Netscout Systems

UPDATE: Jefferies Raises PT to $42 on Cepheid

UPDATE: Jefferies Raises PT to $42 on Cepheid

J.P. Morgan Maintains Neutral Rating and $14 PT on Seagate Technology

J.P. Morgan Maintains Neutral Rating and $14 PT on Seagate Technology

UPDATE: J.P. Morgan Raises PT to $35 on Synaptics

UPDATE: J.P. Morgan Raises PT to $35 on Synaptics

UPDATE: Jefferies Lowers PT to $10.50 on Compuware

UPDATE: Jefferies Lowers PT to $10.50 on Compuware

Jefferies Maintains Hold Rating and $18 PT on MB Financial

Jefferies Maintains Hold Rating and $18 PT on MB Financial

J.P. Morgan Maintains Neutral Rating and $16 PT on Fifth Third Bancorp

J.P. Morgan Maintains Neutral Rating and $16 PT on Fifth Third Bancorp

UPDATE: J.P. Morgan Lowers PT to $54 on Syntel

UPDATE: J.P. Morgan Lowers PT to $54 on Syntel

J.P. Morgan Raises PT to $420 on MasterCard

J.P. Morgan Raises PT to $420 on MasterCard

UPDATE: J.P. Morgan Raises PT to $62 on O'Reilly Automotive

UPDATE: J.P. Morgan Raises PT to $62 on O'Reilly Automotive

UPDATE: J.P. Morgan Raises PT to $320 on Chipotle Mexican Grill

UPDATE: J.P. Morgan Raises PT to $320 on Chipotle Mexican Grill

UPDATE: J.P. Morgan Raises PT to $50 on Acacia Research

UPDATE: J.P. Morgan Raises PT to $50 on Acacia Research

J.P. Morgan Lowers PT to $53 on Crown Castle

J.P. Morgan Lowers PT to $53 on Crown Castle

J.P. Morgan Maintains Neutral Rating and $43 PT on GeoEye

J.P. Morgan Maintains Neutral Rating and $43 PT on GeoEye

J.P. Morgan Maintains Neutral Rating and $6.50 PT on Telecommunication Systems

J.P. Morgan Maintains Neutral Rating and $6.50 PT on Telecommunication Systems

Morgan Stanley Maintains Overweight Rating on Pfizer

Morgan Stanley Maintains Overweight Rating on Pfizer

Piper Jaffray Maintains Neutral Rating and $11 PT on the Dolan Company

Piper Jaffray Maintains Neutral Rating and $11 PT on the Dolan Company

Piper Jaffray Lowers PT to $42 on Altera

Piper Jaffray Lowers PT to $42 on Altera